CLIVATUZUMAB TETRAXETAN
UNII 1D1F7UG35J

Substance Identification & Data

This profile provides standardized clinical and technical data for Clivatuzumab Tetraxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1D1F7UG35J.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1462876-11-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1D1F7UG35J

CAS Registry Number

1462876-11-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CLIVATUZUMAB TETRAXETAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166491

National Cancer Institute reference terminology for clinical and research data.

INN ID

10103

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

BC-60

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Clivatuzumab Tetraxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CLIVATUZUMAB TETRAXETAN

Common Names & Synonyms

CLIVATUZUMAB TETRAXETAN [INN]

CLIVATUZUMAB TETRAXETAN [USAN]

IMMUNOGLOBULIN G1, ANTI-(MUCIN) (HUMAN-MUS MUSCULUS MONOCLONAL HPAM4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HPAM4 .KAPPA.-CHAIN, DIMER, 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID CONJUGATE